Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medicare coverage for oncology services

G P Bagley1, K McVearry

  • 1Health Care Financing Administration, Office of Clinical Standards and Quality, Coverage and Analysis Group, Baltimore, MD 21244-1850, USA.

Cancer
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medicare coverage policies: A macro and micro analysis.

Journal of thrombosis and thrombolysis·2000
Same author

The Health Care Financing Administration cryosurgery decision: a timely response to new data.

The Journal of urology·1999
Same author

Food labeling reforms for 1992.

American family physician·1992
Same author

Update on breast implants.

American family physician·1992
Same author

Development of human palmar and digital flexion creases.

The Journal of pediatrics·1988
Same author

Mulligan Hood removed through the laparoscope.

Obstetrics and gynecology·1972
Same journal

Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

Cancer·2026
Same journal

Bendamustine in indolent lymphoma: Letting the dust settle down.

Cancer·2026
Same journal

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

Cancer·2026
Same journal

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Cancer·2026
Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
See all related articles

Medicare ensures healthcare security by covering reasonable and necessary oncology services. Recent legislation expanded coverage for cancer screenings and treatments, demonstrating a commitment to beneficiary care.

Area of Science:

  • Health Policy
  • Oncology Services
  • Healthcare Administration

Background:

  • Medicare, established by Title XVIII of the Social Security Act, aims to provide health care security.
  • The Health Care Financing Administration (HCFA) has discretionary authority to determine coverage for services.
  • Coverage decisions are based on whether services are reasonable and necessary for diagnosis, treatment, or functional improvement.

Purpose of the Study:

  • To outline Medicare's coverage policies for oncology services.
  • To explain the criteria for determining reasonable and necessary medical services.
  • To highlight recent legislative expansions in cancer screening and treatment coverage.

Main Methods:

  • Reliance on authoritative evidence, including federal agency approvals (e.g., FDA) and scientific literature evaluations.

Related Experiment Videos

  • Implementation of 'coverage with conditions' for promising but evolving medical services.
  • Analysis of legislative mandates, such as the Balanced Budget Act of 1997 (BBA '97).
  • Main Results:

    • Medicare covers reasonable and necessary diagnostic and therapeutic cancer-related services not otherwise prohibited.
    • The BBA '97 mandated expanded coverage for mammography, Papanicolaou smears, pelvic exams, prostate cancer screening, and colorectal screening.
    • Coverage policies also extend to antiemetic drugs for chemotherapy and specific cancer drugs (Group C).

    Conclusions:

    • Medicare's coverage of oncology services is determined by established policies and evidence-based criteria.
    • Legislative actions have broadened access to important cancer prevention and treatment services for beneficiaries.
    • HCFA continues to monitor oncology service advancements to establish future national coverage policies.